Skip to content

Author

A. Boulmpou

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Treatment differences and outcomes among myocardial infarction patients without standard modifiable risk factors: Data from CALLINICUS-Hellas Registry

It is increasingly recognized that patients might suffer from acute coronary syndrome (ACS) in the absence of standard modifiable risk factors (SMuRFs). Their treatment remains empirical. We examined the impact of SMuRF-less status on in-hospital management and long term outcomes. CALLINICUS-Hellas...

K. Papathanasiou, P. Kalogeras, S. Rallidis et al. · 0 citations
Open access Oct 2026

Feasibility analysis of longitudinal strain assessment in patients undergoing contrast and non-contrast enhanced stress echocardiography

Stress echocardiography (SE) is an established method for detecting myocardial ischemia based on visual assessment of wall-motion abnormalities during exercise or dobutamine stress [1,5]. To overcome the limitations of qualitative evaluation, quantitative assessment of regional contractility using deformation ima...

V. Schismenos, V. Tsavidi, K. Fameliari et al. · 0 citations
Open access Sep 2026

Prospective Evaluation of Quality‐of‐Life Improvement After Dapagliflozin Initiation in a Greek Population With HFrEF: The EVOLUTION‐HF 12‐Month Results

Heart failure with reduced ejection fraction (HFrEF), defined by a left ventricular ejection fraction ≤ 40%, remains a major global health challenge, associated with substantial morbidity, mortality, and impaired quality of life (QoL), particularly in patients with higher NYHA class. Sodium–glucose cotransporter‐2 (SGL...

V. Potoupni, A. Boulmpou, S. Maragkoudakis et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.